MelissaJoanReimerMD

HIV/AIDS Medicine, International Health, Travel & Tropical

UNC Fogarty Global Health Fellow, Lilongwe, Malawi

Dr. Reimer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
2015 Thomas St
Houston, TX 77009
Phone+1 713-873-4000

Fax+1 713-500-5495

Dr. Melissa Reimer-McAtee is an infectious disease specialist living and working in Lilongwe, Malawi as a Fogarty Global Health Fellow. She received her medical degree from University of South Alabama College of Medicine, Internal Medicine residency from Tulane Medical Center, and Infectious Diseases fellowship training from University of Texas Health Sciences Center in Houston.

University of Texas Health Science Center at HoustonFellowship, Infectious Disease, 2018 - 2020
Tulane UniversityResidency, Internal Medicine, 2012 - 2015
University of South Alabama College of MedicineClass of 2012

HIV And Parasitic Infection (HAPI) Study Start of enrollment: 2022 May 02
Completed
Not Applicable

PubMed

Correction to: Encephalitis in HIV‑infected adults in the antiretroviral therapy era.
Melissa Reimer-McAtee, Denisse Ramirez, Casey L McAtee, Alejandro Granillo, Rodrigo Hasbun
Journal of Neurology. 2023-09-01
Encephalitis in HIV-infected adults in the antiretroviral therapy era.
Melissa Reimer-Mcatee, Denisse Ramirez, Casey Mcatee, Alejandro Granillo, Rodrigo Hasbun
Journal of Neurology. 2023-08-01
13 citations
HIV and Chagas Disease: An Evaluation of the Use of Real-Time Quantitative Polymerase Chain Reaction to Measure Levels of Trypanosoma cruzi Parasitemia in HIV Patients...
Melissa J. Reimer-McAtee, Carolina Mejia, Taryn Clark, Jules Terle, Monica J. Pajuelo
The American Journal of Tropical Medicine and Hygiene. 2021-09-15

Journal Articles

Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study
James Welker 1, Juan D Pulido 2, Andrew T Catanzaro 3, Carlos D Malvestutto 4, Zihai Li 5, Jonathan B Cohen 3, Eric D Whitman 6, Dana Byrne 7, Olivia K Giddings 8, Jor..., Lancet Infectious Disease, 5/2022
Use of a Chagas Urine Nanoparticle Test (Chunap) to Correlate with Parasitemia Levels in T. cruzi/HIV Co-infected Patients
Yagahira E Castro-Sesquen 1 2, Robert H Gilman 3, Carolina Mejia 4, Daniel E Clark 5, Jeong Choi 6, Melissa J Reimer-McAtee 7, Rosario Castro 8, Edward Valencia-Ayala ..., PLOS NTD, 2/2016
Evaluation of Microscopic Observation Drug Susceptibility (MODS) and the string test for rapid diagnosis of pulmonary tuberculosis in HIV/AIDS patients in Bolivia
Meredith H Lora, Melissa J Reimer-McAtee, Robert H Gilman, Daniel Lozano, Ruth Saravia, Monica Pajuelo, Caryn Bern, Rosario Castro, Magaly Espinoza, Maya Vallejo, Marc..., BMC ID, 6/2015